Physician profile
Ninh Ba Doan
NPI 1477852739
$9,033.02
in general payments reported to CMS, 2019-2025
25 companies · $453 in 2025
The $453 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,042 · 2020: $2,052 · 2021: $2,007 · 2022: $573 · 2023: $751 · 2024: $156 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $4,311.22 | 2019-2020 | |
| Medtronic, INC. | $1,254.71 | 2021-2025 | Mazor X System, Midas Rex |
| Si-Bone, INC. | $665.97 | 2019-2021 | |
| Boston Scientific Corporation | $520.21 | 2019-2025 | Artisan, Infinion 16, Wavewriter Alpha Prime 16 |
| Mirus, LLC | $432.06 | 2021 | |
| Providence Medical Technology, INC. | $390.72 | 2021-2024 | |
| Abbvie INC. | $177.72 | 2025 | |
| Surgalign Spine Technologies, INC. | $152.13 | 2019-2020 | |
| Depuy Synthes Sales INC. | $135.96 | 2019 | |
| Intrinsic Therapeutics | $122.58 | 2021 | |
| Orthofix Medical, INC. | $105.87 | 2019 | |
| Integra Lifesciences Corporation | $101.52 | 2021-2022 | |
| Novocure INC. | $93.17 | 2020 | |
| Nuvasive, INC. | $85.75 | 2021 | |
| Arbor Pharmaceuticals, INC. | $84.14 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Elements, INC. | $76.77 | 2021 | |
| Abbott Laboratories | $73.77 | 2022-2024 | Proclaim |
| Azurity Pharmaceuticals, INC. | $53.03 | 2023 | Gliadel |
| Stryker Corporation | $52.93 | 2025 | N/A |
| Arteriocyte Medical Systems, INC. | $43.21 | 2025 | Magellan |
| Alnylam Pharmaceuticals INC. | $24.70 | 2019 | |
| Kls-Martin L.P. | $23.60 | 2022 | |
| Brainscope Company, INC. | $18.72 | 2022 | |
| Ethicon US, LLC | $17.24 | 2025 | Surgicel Nu-Knit, Vistaseal, Evarrest |
| Grifols USA, LLC | $15.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ninh Doan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.